ALG-000111

N/A

Report date: 2025/03/19 16:06:38
NME

Base Information

Drug NameALG-000111
Drug Alias NameALG-000111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulatorsHBV DNA Polymerase inhibitors
TargetsCapsid proteinHBV DNA Polymerase
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAligos Belgium BV
China Registration ClassN/A

Develop Information

Active CompaniesAligos Belgium BV
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A